Lipoid pneumonia classification
Jump to navigation
Jump to search
|
Lipoid pneumonia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lipoid pneumonia classification On the Web |
|
American Roentgen Ray Society Images of Lipoid pneumonia classification |
|
Risk calculators and risk factors for Lipoid pneumonia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Lipoid pneumonia may be classified according to source of the lipid exposure into 2 subtypes: Exogenous, more common type reported, due to aspiration or inhalation of fatty substance, and endogenous, due to obstructive pneumonia.
Classification
- Lipoid pneumonia may be classified according to source of the lipid exposure into 2 subtypes:[1][2]
| Lipoid pneumonia classification | |||||||||||||||||||||||||
| Exogenus: More common type reported, due to aspiration or inhalation of fatty substance. | Endogenus: Due to obstructive pneumonia. | ||||||||||||||||||||||||
| Type I | Type II | Type III | |||||||||||||||||||||||
- Endogenous pneumonia further divide into 3 subgroups:[3]
- Type I: Localized to the lung parenchyma distal to an airway obstructed by a tumor.
- Type II: Features of type I lipoid pneumonia and consecutively spreading to the adjacent segment whose airway is not affected.
- Type III: Features of type II lipoid pneumonia and spreading to isolated segments.
References
- ↑ BARON E (1950). "Lipoid pneumonia due to the use of mineral oil as a laxative". Va Med Mon (1918). 77 (9): 448–50. PMID 15443468.
- ↑ Gondouin, A.; Manzoni, Ph.; Ranfaing, E.; Brun, J.; Cadranel, J.; Sadoun, D.; Cordier, J.F.; Depierre, A.; Dalphin, J.C. (1996). "Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France". European Respiratory Journal. 9 (7): 1463–1469. doi:10.1183/09031936.96.09071463. ISSN 0000-0000.
- ↑ Tamura, A.; Hebisawa, A.; Fukushima, K.; Yotsumoto, H.; Mori, M. (1998). "Lipoid Pneumonia in Lung Cancer: Radiographic and Pathological Features". Japanese Journal of Clinical Oncology. 28 (8): 492–496. doi:10.1093/jjco/28.8.492. ISSN 0368-2811.